Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Osteoactivin

Osteoactivin

Brief Information

Name:Transmembrane glycoprotein NMB
Target Synonym:Transmembrane Glycoprotein,HGFIN,Transmembrane glycoprotein NMB,Hematopoietic growth factor inducible neurokinin-1 type,GPNMB,Glycoprotein Nmb,Hematopoietic Growth Factor Inducible Neurokinin-1,Glycoprotein Nonmetastatic Melanoma Protein B,Transmembrane Glycoprotein HGFIN,Glycoprotein (Transmembrane) Nmb,Glycoprotein Nmb-Like Protein,Osteoactivin,PLCA3,NMB,UNQ1725/PRO9925
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GPB-H5229 Human Human Osteoactivin / GPNMB Protein, His Tag
GPB-H5229-structure
GPB-H5229-sds
ACRO Quality

Synonym Name

GPNMB,HGFIN,NMB,Osteoactivin

Background

Transmembrane glycoprotein NMB (GPNMB) is also known as Transmembrane glycoprotein HGFIN, DC-HIL and Osteoactivin (OA), which belongs to the PMEL/NMB family. GPNMB contains one PKD domain. GPNMB is a transmembrane glycoprotein that is up-regulated in various cancer cells, including in glioblastoma multiforme and is expressed in many melanoma cells, as well as in tissue macrophages. GPNMB protein acts as a downstream mediator of BMP-2 effects on osteoblast differentiation and function. GPNMB participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Glembatumumab vedotin CR-011; CDX-011; CR-011-ADC; CR011-vcMMAE Phase 2 Clinical Celldex Therapeutics Solid tumours; Triple Negative Breast Neoplasms; Osteosarcoma; Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma Details
Glembatumumab vedotin CR-011; CDX-011; CR-011-ADC; CR011-vcMMAE Phase 2 Clinical Celldex Therapeutics Solid tumours; Triple Negative Breast Neoplasms; Osteosarcoma; Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap